Pub Date : 2020-09-14DOI: 10.36227/TECHRXIV.12943469.V1
Syed Abdullah Basit, R. Qureshi, A. Shahid, Sheheryar Khan
Among all kinds of cancer, lung cancer has the greatest fatality rate. The mutation in Epidermal growth factor receptor (EGFR) is a significant cause of cancer deaths. Lung cancer is often diagnosed at advanced cancer stages. In this work, we propose a model by integrating patient's personal information and molecular features using machine learning classifiers, and molecular dynamics simulation. The clinical information is taken from various published studies, and molecular features are extracted using the drug-protein interactions and binding free energy of the drug-protein complex. The proposed model achieves good accuracy with a random forest classifier and a deep neural network. We believe that the prediction can be a promising index, and may help physicians and oncologists to develop personalized therapies for lung cancer patients.
{"title":"Survival prediction of lung cancer patients by integration of clinical and molecular features using machine learning","authors":"Syed Abdullah Basit, R. Qureshi, A. Shahid, Sheheryar Khan","doi":"10.36227/TECHRXIV.12943469.V1","DOIUrl":"https://doi.org/10.36227/TECHRXIV.12943469.V1","url":null,"abstract":"Among all kinds of cancer, lung cancer has the greatest fatality rate. The mutation in Epidermal growth factor receptor (EGFR) is a significant cause of cancer deaths. Lung cancer is often diagnosed at advanced cancer stages. In this work, we propose a model by integrating patient's personal information and molecular features using machine learning classifiers, and molecular dynamics simulation. The clinical information is taken from various published studies, and molecular features are extracted using the drug-protein interactions and binding free energy of the drug-protein complex. The proposed model achieves good accuracy with a random forest classifier and a deep neural network. We believe that the prediction can be a promising index, and may help physicians and oncologists to develop personalized therapies for lung cancer patients.","PeriodicalId":325357,"journal":{"name":"2021 15th International Conference on Open Source Systems and Technologies (ICOSST)","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128564714","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：